PARP10 and cardiac hypertrophy: CHAPIR directly interacted with METTL3 which suppresses the m6A modification of Parp10 mRNAs thereby increasing Parp10 protein levels and promoting NFATC4‐induced pathological cardiac hypertrophy (Gao et al., 2020).